Your browser is no longer supported. Please, upgrade your browser.
Settings
SPPI [NASD]
Spectrum Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-1.25 Insider Own1.40% Shs Outstand145.37M Perf Week16.49%
Market Cap722.50M Forward P/E- EPS next Y-0.47 Insider Trans-19.44% Shs Float137.35M Perf Month42.17%
Income-166.30M PEG- EPS next Q-0.26 Inst Own64.60% Short Float11.38% Perf Quarter20.60%
Sales- P/S- EPS this Y-12.50% Inst Trans1.72% Short Ratio5.55 Perf Half Y-5.12%
Book/sh0.84 P/B5.30 EPS next Y47.70% ROA-77.20% Target Price- Perf Year56.69%
Cash/sh1.00 P/C4.44 EPS next 5Y- ROE-112.30% 52W Range2.68 - 5.24 Perf YTD30.50%
Dividend- P/FCF- EPS past 5Y-11.20% ROI- 52W High-15.08% Beta2.19
Dividend %- Quick Ratio3.60 Sales past 5Y- Gross Margin- 52W Low66.05% ATR0.20
Employees176 Current Ratio3.60 Sales Q/Q- Oper. Margin- RSI (14)81.99 Volatility6.40% 5.71%
OptionableYes Debt/Eq0.00 EPS Q/Q32.50% Profit Margin- Rel Volume0.60 Prev Close4.39
ShortableYes LT Debt/Eq0.00 EarningsMay 13 AMC Payout- Avg Volume2.81M Price4.45
Recom2.20 SMA2022.77% SMA5035.14% SMA20018.18% Volume1,679,508 Change1.37%
Sep-17-20Initiated JMP Securities Mkt Outperform $12
Dec-26-19Downgrade Guggenheim Buy → Neutral
Dec-26-19Downgrade Cantor Fitzgerald Overweight → Neutral $17 → $4
Nov-27-19Resumed B. Riley FBR Buy $18
Jul-11-19Initiated B. Riley FBR Buy $18
Mar-15-19Resumed Jefferies Buy $21
Nov-12-18Reiterated B. Riley FBR Buy $35 → $29
Dec-18-17Initiated B. Riley FBR, Inc. Buy $26
Oct-24-17Initiated Guggenheim Buy $32
Oct-19-17Reiterated H.C. Wainwright Buy $20 → $29
Oct-04-17Reiterated H.C. Wainwright Buy $14 → $20
Aug-16-17Resumed H.C. Wainwright Buy $14
Feb-10-17Resumed Jefferies Buy
Nov-05-15Reiterated RBC Capital Mkts Outperform $13 → $12
Aug-07-15Reiterated RBC Capital Mkts Outperform $12 → $13
Apr-02-15Initiated FBR Capital Outperform $9
Feb-23-15Downgrade ROTH Capital Buy → Neutral $15 → $7
Jul-15-14Upgrade R. F. Lafferty Sell → Neutral $7.50
Oct-07-13Initiated HC Wainwright Buy $15
May-29-13Initiated Burrill Institutional Research Mkt Outperform $12
Jun-04-21 09:00AM  
Jun-01-21 07:00AM  
04:50AM  
May-28-21 07:00AM  
May-27-21 07:00AM  
May-13-21 08:30PM  
04:00PM  
02:30PM  
May-06-21 07:00AM  
Apr-10-21 08:30AM  
Apr-05-21 07:00AM  
Mar-30-21 08:00PM  
04:00PM  
Mar-26-21 04:00PM  
Mar-16-21 07:00AM  
Mar-12-21 09:33AM  
Mar-11-21 08:19AM  
07:00AM  
06:06AM  
Mar-03-21 03:00AM  
Mar-02-21 11:45AM  
Feb-26-21 07:00AM  
Feb-23-21 07:00AM  
Feb-04-21 07:00AM  
Jan-22-21 07:00AM  
Jan-05-21 07:00AM  
Dec-23-20 08:29AM  
Dec-22-20 04:05PM  
Dec-17-20 08:00AM  
Dec-14-20 07:07AM  
07:00AM  
Dec-04-20 07:00AM  
Dec-03-20 02:45AM  
Nov-16-20 05:34PM  
Nov-09-20 07:00AM  
Nov-04-20 09:32PM  
05:35PM  
04:25PM  
04:00PM  
02:30PM  
Oct-28-20 07:00AM  
Oct-26-20 07:23AM  
07:00AM  
Sep-21-20 09:04AM  
Sep-18-20 07:00AM  
Sep-17-20 09:41AM  
Sep-16-20 08:42AM  
Sep-14-20 07:00AM  
Sep-08-20 07:00AM  
Sep-04-20 02:21PM  
Aug-10-20 08:30PM  
05:35PM  
04:00PM  
Aug-05-20 04:00PM  
Aug-03-20 07:00AM  
Jul-30-20 12:59PM  
07:00AM  
Jul-29-20 04:27PM  
Jul-28-20 12:00PM  
08:44AM  
03:32AM  
Jul-27-20 04:00PM  
Jul-16-20 09:00AM  
Jul-02-20 08:51AM  
Jun-25-20 11:23AM  
Jun-22-20 09:00AM  
Jun-21-20 10:39PM  
Jun-17-20 07:58PM  
Jun-16-20 07:00AM  
Jun-06-20 11:31AM  
Jun-05-20 03:37AM  
Jun-03-20 04:00PM  
May-27-20 07:00AM  
May-11-20 10:41AM  
May-08-20 11:00PM  
May-07-20 04:00PM  
May-01-20 07:00AM  
Apr-30-20 07:00AM  
Apr-28-20 07:00AM  
Apr-23-20 07:00AM  
Apr-21-20 07:00AM  
Apr-14-20 10:37AM  
Mar-28-20 11:30AM  
Mar-17-20 11:12AM  
07:00AM  
Mar-11-20 07:00AM  
Mar-03-20 07:00AM  
Mar-02-20 08:00AM  
Feb-28-20 08:46AM  
Feb-27-20 04:00PM  
Feb-20-20 09:27AM  
07:00AM  
Feb-06-20 07:00AM  
Jan-17-20 05:50PM  
Jan-15-20 01:39PM  
Dec-27-19 02:50PM  
08:05AM  
07:59AM  
06:56AM  
Dec-26-19 03:57PM  
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include ROLONTIS, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor for non-small cell lung cancer tumors with various mutations; and Anti-CD20-IFNa, an antibody-interferon fusion molecule directed against CD20 that is in Phase I development for the treatment of patients with relapsed or refractory non-Hodgkin's lymphoma, including diffuse large B-cell lymphoma. It has co-development, commercialization, and in-license agreements with Hanmi Pharmaceutical Co. Ltd.; a patent and technology license agreement with The University of Texas M.D. Anderson Cancer Center; and in-license agreement with ImmunGene, Inc. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Henderson, Nevada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Riga Thomas JEVP, COO & CCOMay 14Sale3.072,2506,908406,879May 14 07:31 PM
McGahan Keith MChief Legal OfficerMay 14Sale3.075251,612311,934May 14 07:27 PM
McGahan Keith MChief Legal OfficerMay 13Sale3.094341,339312,459May 14 07:27 PM
Riga Thomas JEVP, COO & CCOMay 13Sale3.093,40210,499409,129May 14 07:31 PM
LEBEL FRANCOISChief Medical OfficerApr 06Sale3.241,0253,321350,867Apr 06 05:50 PM
LEBEL FRANCOISChief Medical OfficerApr 05Sale3.311,1253,726351,892Apr 06 05:50 PM
GUSTAFSON KURT AEVP & Chief Financial OfficerMar 16Sale3.6916,31860,213400,451Mar 17 06:08 PM
LEBEL FRANCOISChief Medical OfficerMar 16Sale3.6918,82869,475353,017Mar 17 06:08 PM
McGahan Keith MChief Legal OfficerMar 16Sale3.6916,31860,213316,832Mar 17 06:51 PM
Riga Thomas JEVP, COO & CCOMar 16Sale3.6918,82869,475412,531Mar 17 06:52 PM
Turgeon Joseph W.CEO & PresidentMar 16Sale3.6928,243104,217565,028Mar 17 06:53 PM
Turgeon Joseph W.CEO & PresidentMar 15Sale3.6240,091145,330593,271Mar 17 06:53 PM
Riga Thomas JEVP, COO & CCOMar 15Sale3.6223,29184,430431,359Mar 17 06:52 PM
McGahan Keith MChief Legal OfficerMar 15Sale3.6214,36252,062333,150Mar 17 06:51 PM
LEBEL FRANCOISChief Medical OfficerMar 15Sale3.6222,63182,037371,845Mar 17 06:08 PM
GUSTAFSON KURT AEVP & Chief Financial OfficerMar 15Sale3.6220,36573,823416,769Mar 17 06:08 PM
Turgeon Joseph W.CEO & PresidentFeb 22Sale3.737,50027,975633,362Feb 23 05:00 PM
Riga Thomas JEVP, COO & CCOFeb 22Sale3.735,00018,650454,650Feb 23 04:19 PM
GUSTAFSON KURT AEVP & Chief Financial OfficerFeb 22Sale3.734,00014,920437,134Feb 23 04:27 PM
McGahan Keith MChief Legal OfficerFeb 22Sale3.734,00014,920347,512Feb 23 04:33 PM
McGahan Keith MChief Legal OfficerFeb 19Sale3.643,29511,984351,512Feb 23 04:33 PM
GUSTAFSON KURT AEVP & Chief Financial OfficerFeb 19Sale3.644,67216,992441,134Feb 23 04:27 PM
Riga Thomas JEVP, COO & CCOFeb 19Sale3.645,01818,250459,650Feb 23 04:19 PM
Turgeon Joseph W.CEO & PresidentFeb 19Sale3.647,25726,394640,862Feb 23 05:00 PM
McGahan Keith MChief Legal OfficerFeb 10Sale3.932,5009,825244,498Feb 10 05:29 PM
McGahan Keith MChief Legal OfficerFeb 09Sale3.931,9777,770246,998Feb 10 05:29 PM
Turgeon Joseph W.CEO & PresidentJan 20Sale4.313,88916,762370,029Jan 20 08:33 PM
GUSTAFSON KURT AEVP & Chief Financial OfficerJan 20Sale4.311,9448,379330,608Jan 20 08:33 PM
Riga Thomas JEVP, COO & CCOJan 20Sale4.3110,00043,100330,258Jan 20 08:34 PM
Riga Thomas JEVP, COO & CCOJan 19Sale3.9776,283302,894340,258Jan 20 08:34 PM
GUSTAFSON KURT AEVP & Chief Financial OfficerJan 19Sale3.812,5829,832332,552Jan 20 08:33 PM
Turgeon Joseph W.CEO & PresidentJan 19Sale3.813,84414,638373,918Jan 20 08:33 PM
Turgeon Joseph W.CEO & PresidentDec 16Sale4.70150,899709,225377,762Dec 18 07:18 PM
GUSTAFSON KURT AEVP & Chief Financial OfficerDec 14Sale5.0025,696128,480335,134Dec 16 05:16 PM
Turgeon Joseph W.CEO & PresidentNov 18Sale4.13162,473671,013528,661Nov 20 05:10 PM
LEBEL FRANCOISChief Medical OfficerNov 09Sale3.565,00017,800306,424Nov 09 08:08 PM
LEBEL FRANCOISChief Medical OfficerNov 06Sale3.507,02524,609301,424Nov 09 08:08 PM
McGahan Keith MChief Legal OfficerAug 12Sale3.71250928248,769Aug 12 05:44 PM
McGahan Keith MChief Legal OfficerAug 11Sale4.032941,183249,019Aug 12 05:44 PM
McGahan Keith MChief Legal OfficerJul 09Sale3.3613,88146,640249,313Jul 09 06:24 PM
McGahan Keith MChief Legal OfficerJun 24Sale3.2115,77350,631262,986Jun 25 05:01 PM
LEBEL FRANCOISChief Medical OfficerJun 23Sale3.354,16713,959292,729Jun 23 05:23 PM
LEBEL FRANCOISChief Medical OfficerJun 22Sale3.165,47417,320296,896Jun 23 05:23 PM
Ashton WilliamDirectorJun 22Sale3.255,00016,25041,666Jun 23 04:30 PM
McGahan Keith MChief Legal OfficerJun 22Sale3.253,0009,750278,759Jun 23 04:11 PM
McGahan Keith MChief Legal OfficerJun 19Sale3.133,45910,820281,759Jun 23 04:11 PM